Lu, L.; Cole, A.; Huang, D.; Wang, Q.; Guo, Z.; Yang, W.; Lu, J.
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer. Biomolecules 2022, 12, 203.
https://doi.org/10.3390/biom12020203
AMA Style
Lu L, Cole A, Huang D, Wang Q, Guo Z, Yang W, Lu J.
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer. Biomolecules. 2022; 12(2):203.
https://doi.org/10.3390/biom12020203
Chicago/Turabian Style
Lu, Lucy, Adam Cole, Dan Huang, Qiang Wang, Zhongming Guo, Wancai Yang, and Jim Lu.
2022. "Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer" Biomolecules 12, no. 2: 203.
https://doi.org/10.3390/biom12020203
APA Style
Lu, L., Cole, A., Huang, D., Wang, Q., Guo, Z., Yang, W., & Lu, J.
(2022). Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer. Biomolecules, 12(2), 203.
https://doi.org/10.3390/biom12020203